Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

PT-141 Downstream Effects: Research Applications Comparison

Vascular function studies eNOS activation → NO release → cGMP elevation → smooth muscle relaxation Systemic vasodilation, reduced arterial pressure, increased tissue perfusion 45–60 minutes 6–8 hours Most reliable downstream effect with consistent dose-respons

This comparison does not assign a generated winner or score.

  • Vascular function studies
  • eNOS activation → NO release → cGMP elevation → smooth muscle relaxation
  • Systemic vasodilation, reduced arterial pressure, increased tissue perfusion
  • 45–60 minutes
  • 6–8 hours
  • Most reliable downstream effect with consistent dose-response relationship across models
  • Neurotransmitter modulation research
  • MC4R in PVN → oxytocin release → D2 receptor sensitization
  • Indirect dopamine potentiation, CREB phosphorylation in limbic structures
  • 30–45 minutes
  • 4–6 hours
  • Highly variable between subjects due to baseline dopaminergic tone differences
  • Melanocortin receptor mapping
  • MC3R/MC4R activation → cAMP elevation → PKA phosphorylation cascade
  • CREB activation, gene transcription changes, receptor desensitization over repeated dosing
  • 15–30 minutes (biochemical), 60–90 minutes (behavioral)
  • 8–12 hours (signaling), 2–4 hours (subjective)
  • Gold standard for studying melanocortin system function without confounding MC1R/MC5R activity
  • Metabolic signaling studies
  • MC3R in adipose tissue → HSL activation → lipolysis
  • Increased free fatty acid mobilization, temporary insulin sensitivity improvement
  • 60–90 minutes
  • Limited clinical relevance. Effect magnitude insufficient for therapeutic metabolic intervention
More references

Related material